| 06-25-2012 09:26 PM CET - Health & Medicine |
|
A first for Portugal: Diapharm obtains registration for a traditional medicinal product with Agnus Castus
Press release from: Diapharm
PR Agency: co-operate Wegener & Rieke GmbH

Diapharm’s tablets containing Agnus Castus extract have been approved for the treatment of premenstrual symptoms by the Portuguese
According to Dr. Rainer Kolkmann, herbal medicinal products often have regional traditions. One herb may have been established for decades in one EU country but can be almost unheard of in others. The THMP Directive 2004/24/EC is an opportunity to increase awareness of medicinal products such as these across Europe, but the industry and authorities have been hesitant at making use of the Directive. Pharmaceutical service provider Diapharm currently has around 20 dossiers and registrations for traditional herbal products in its portfolio and is ready to assign licensing rights and approvals to medicinal product manufacturers throughout Europe.
Diapharm is an international full-service provider to the healthcare industry. Founded in 1988, Diapharm supports pharmaceutical companies in all questions concerning regulatory affairs, medical & clinical development, quality management and business development. Its activities focus on the sectors of medicinal products, food supplements and dietetic food, medical devices and cosmetics. With about 100 employees in Germany, Austria, Romania and the United Kingdom, Diapharm is at the service of multinational companies as well as of recent start-ups and small to mid-sized businesses.
Contact:
Diapharm
Press Office
Hafenweg 18-20
D-48155 Münster
Contact person:
Nicole Sibbing
Tel.: +49 (0)251 - 60935-517
nicole.sibbing@diapharm.de
www.diapharm.de
Agency contact:
co-operate Wegener & Rieke GmbH
Zumsandestraße 32
D-48145 Münster
Contact person:
Christian Rieke
Tel.: +49 (0)251 - 3222611
wort@co-operate.net
www.co-operate.net
This release was published on openPR.
News-ID: 226703
More releases
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
© openPR 2012 | Imprint
More Releases from
Diapharm
Comments about openPR
OpenPR ist the nicest and most clearly laid out PR platform I have seen to this day. The press releases are displayed very nicely and clearly and without any unnecessary frills.
The updates are fast and the finished release looks appealing and is clearly legible.
Even with 16 years of experience one discovers new things from time to time.
Congratulations!
Gabriele Ketterl,Director Marketing & PR, Menads
The updates are fast and the finished release looks appealing and is clearly legible.
Even with 16 years of experience one discovers new things from time to time.
Congratulations!
Gabriele Ketterl,Director Marketing & PR, Menads

